DNA Today Podcast: Whole Genome Sequencing and Multiomics Tools Closing the Rare Disease Diagnostic Gap
Despite advances in genetic testing, many patients with suspected rare diseases still spend years searching for answers. In this DNA Today episode, Dr. Christine Eng and Chris Sands of Baylor Genetics discuss how Whole Genome Sequencing, enhanced with technologies like RNA Sequencing, long-read sequencing, and optical genome mapping, is helping providers move beyond single-test approaches to deliver clearer, more actionable diagnoses.
Tune in to the full episode on DNA Today to hear how these advances are helping close the diagnostic gap and what they mean for providers and their patients.
About Baylor Genetics
Baylor Genetics is a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, from clinical-grade genomic sequencing to expert interpretation, including Whole Genome Sequencing, Whole Exome Sequencing, and focused panels. Baylor Genetics combines rapid and comprehensive precision diagnostics options with the support of genetic counselors to help clinicians avoid a lengthy diagnostic odyssey for their patients, guide medical management, and ensure no patient with a genetic disorder gets left behind. Baylor Genetics’ testing menu covers family planning, pregnancy, neonatal and pediatric testing, oncology, pharmacogenomics and many other specialized testing options. Located in Houston’s Texas Medical Center, Baylor Genetics serves clients in 50 states.
